New functional assay of P-glycoprotein activity using Hoechst 33342

Schinkel, 2003, Adv. Drug Deliv. Rev., 55, 3, 10.1016/S0169-409X(02)00169-2 Hoffmann, 2004, Drug Metab. Rev., 36, 669, 10.1081/DMR-200033473 Lee, 2004, Curr. Med. Chem. Anticancer Agents, 4, 53, 10.2174/1568011043482197 Shapiro, 1997, Eur. J. Biochem., 250, 130, 10.1111/j.1432-1033.1997.00130.x Kondratov, 2001, Proc. Natl. Acad. Sci. U.S.A., 98, 14078, 10.1073/pnas.241314798 Martin, 2000, Mol. Pharmacol., 58, 624, 10.1124/mol.58.3.624 Roe, 1999, Bioorg. Med. Chem. Lett., 9, 595, 10.1016/S0960-894X(99)00030-X Loo, 2005, J. Membr. Biol., 206, 173, 10.1007/s00232-005-0792-1 Pleban, 2005, Mol. Pharmacol., 67, 365, 10.1124/mol.104.006973 Pajeva, 2002, J. Med. Chem., 45, 5671, 10.1021/jm020941h Spoelstra, 1991, Biochem. Pharmacol., 41, 349, 10.1016/0006-2952(91)90531-9 Bakker, 1997, Int. J. Cancer, 73, 362, 10.1002/(SICI)1097-0215(19971104)73:3<362::AID-IJC10>3.0.CO;2-F Sasaki, 1991, Gynecol. Oncol., 41, 36, 10.1016/0090-8258(91)90251-Y Manetta, 1996, Gynecol. Oncol., 60, 203, 10.1006/gyno.1996.0026 de Jong, 2001, Cancer Res., 61, 2552 Jekerle, 2006, Int. J. Cancer, 119, 414, 10.1002/ijc.21827 Aihara, 1991, Blood, 77, 2079, 10.1182/blood.V77.9.2079.2079 Okochi, 1997, Leukemia, 11, 1119, 10.1038/sj.leu.2400658 Minderman, 2002, Cytometry, 48, 59, 10.1002/cyto.10111 Wiese, 2001, Curr. Med. Chem., 8, 685, 10.2174/0929867013373138 Tawar, 2003, J. Med. Chem., 46, 3785, 10.1021/jm030114w Tawar, 2003, Biochemistry, 42, 13339, 10.1021/bi034425k Shapiro, 1995, J. Biol. Chem., 270, 16167, 10.1074/jbc.270.27.16167 Shapiro, 1995, J. Bioenerg. Biomembr., 27, 7, 10.1007/BF02110325 Ayesh, 1996, Biochim. Biophys. Acta, 1316, 8, 10.1016/0925-4439(96)00008-7 Shao, 1997, Biochim. Biophys. Acta, 1360, 30, 10.1016/S0925-4439(96)00065-8 Safa, 2004, Curr. Med. Chem. Anticancer Agents, 4, 1, 10.2174/1568011043482142 Shapiro, 1999, Eur. J. Biochem., 259, 841, 10.1046/j.1432-1327.1999.00098.x Druker, 2001, Drugs, 61, 1775, 10.2165/00003495-200161120-00009 Muller, 2004, Int. J. Clin. Pharmacol.Ther., 42, 644, 10.5414/CPP42644 The MDCK-MDR1 cell line was kindly provided by Dr. P. Borst, Netherlands Cancer Institute, Amsterdam, The Netherlands. Wang, 2001, Biochem. Biophys. Res. Commun., 289, 580, 10.1006/bbrc.2001.6000 Lykouras, 2000, Eur. Arch. Psychiatry Clin. Neurosci., 250, 93, 10.1007/s004060070041 Okin, 2002, Circulation, 105, 714, 10.1161/hc0602.103585 Leonessa, 2002, J. Med. Chem., 45, 390, 10.1021/jm010126m Ekins, 2002, Mol. Pharmacol., 61, 964, 10.1124/mol.61.5.964 Ecker, 1999, Mol. Pharmacol., 56, 791 Lee, 1998, Biochemistry, 37, 3594, 10.1021/bi972709x Boer, 1996, Eur. J. Cancer, 32A, 857, 10.1016/0959-8049(95)00661-3 Ecker, 1996, J. Med. Chem., 39, 4767, 10.1021/jm960384x Chiba, 1996, J. Mol. Pharmacol., 49, 1122 Segel, 1976 Shapiro, 1998, Eur. J. Biochem., 254, 181, 10.1046/j.1432-1327.1998.2540181.x Lugo, 2005, Biochemistry, 44, 14020, 10.1021/bi0511179 Globisch, 2006, Bioorg. Med. Chem., 14, 1588, 10.1016/j.bmc.2005.10.058 Pajeva, 2004, J. Med. Chem., 47, 2523, 10.1021/jm031009p Litman, 1997, Biochim. Biophys. Acta, 1361, 159, 10.1016/S0925-4439(97)00026-4 Xia, 2006, Mol. Pharm., 3, 78, 10.1021/mp050034j Gatlik-Landwojtowicz, 2006, Biochemistry, 45, 3020, 10.1021/bi051380+ Mueller, 2004, J. Biomol. Screen., 9, 506, 10.1177/1087057104265386 Garnier-Suillerot, 2001, Curr. Med. Chem., 8, 51, 10.2174/0929867013373967